Psoriasis
News
FDA Issues Guidelines on Developing Biosimilar Products
Original Research
Clobetasol Propionate Spray 0.05% for the Treatment of Moderate to Severe Plaque Psoriasis
Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that...
From the Cosmetic Dermatology Archives
Lasers and Light Devices for Psoriasis, Part 2: PDL, Nd:YAG Laser, CO2 Laser, and PDT
Psoriasis is a common inflammatory skin condition with high morbidity.
Video
Earlier Is Better in Psoriasis Treatment
News
Malignancy Rates Remain Stable in Ustekinumab-Treated Patients
Major Finding: A total of 0.57 cancer events per 100 person-years were reported in 2009 and 0.62 cancer events per 100 person-years were reported...
News
Infliximab Switch Clears Psoriasis in Etanercept Nonresponders
Major Finding: After switching to infliximab, 65% of patients with plaque psoriasis had a Physician Global Assessment score of clear (0) or...
News
Ondansetron Quells Methotrexate-Induced Nausea
News
Preterm Delivery a Risk in Systemic Sclerosis
Major Finding: Preterm deliveries were twice as common in pregnant women with systemic sclerosis, compared with pregnant women in the general...